Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, EXE

CMS Suspends Supervision Requirements for CRNAs


PARK RIDGE, Ill., March 31, 2020 /PRNewswire/ -- (AANA)?The Centers for Medicare & Medicaid Services (CMS) has temporarily suspended physician supervision requirements for Certified Registered Nurse Anesthetists (CRNAs)?an action that the American Association of Nurse Anesthetists (AANA) deems a critical step for CRNAs to serve the U.S. healthcare system more effectively during the COVID-19 pandemic.

According to a March 30 news release, the CMS announced an unprecedented array of temporary regulatory waivers and new rules to equip the American healthcare system with maximum flexibility to respond to the pandemic.

Waiving the requirements will allow states to optimize their healthcare workforce and enable CRNAs to practice at the top of their license. Made possible by President Trump's recent emergency declaration and emergency rule making, the temporary changes will apply immediately across the entire U.S. healthcare system for the duration of the emergency declaration. The regulatory changes allow hospitals and health systems to deliver services at other locations to make room for COVID-19 patients needing acute care in their main facility.

"Removing burdensome restrictions on CRNAs and other healthcare professionals is the right policy at this critical juncture and is desperately needed to meet the growing demands on our healthcare delivery system," said AANA President Kate Jansky, MHS, CRNA, APRN, USA LTC (ret).

"Facilities need maximum flexibility in utilizing CRNAs and other advanced practice registered nurses to manage and staff intensive care units, operating rooms, critical care and other units as patient care requires. CRNAs can play an important role in providing life-saving critical care management for patients impacted by the COVID-19 virus," said Jansky.

Earlier this month, AANA CEO Randall D. Moore, DNP, MBA, CRNA, met with President Trump, Vice President Pence, CMS Administrator Verma and other key senior administration officials at the White House to convey the top priorities of CRNA, nurses, and other healthcare providers as the nation prepared to deepen its response to the pandemic. Along with leaders of other national nursing organizations, Moore requested that federal agencies remove all regulatory barriers for advanced practice nurses and other non-physician providers to practice at the top of their education and training, ensure that all healthcare providers immediately have appropriate personal protective equipment to protect themselves, and ensure a sufficient number of ventilators and other medical equipment to accommodate the anticipated surge of patients impacted by the virus.

SOURCE American Association of Nurse Anesthetists


These press releases may also interest you

at 16:30
Aptose Biosciences Inc. , a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2024, on Tuesday, May...

at 16:30
Spear Education, a leading provider of advanced dental education, today announced the appointment of technology executive Jim Milton to its Board of Directors. Mr. Milton is a recognized leader in the education technology space. He was named Higher...

at 16:30
WELL Health Technologies Corp. ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce...

at 16:30
Centerline Biomedical, Inc. ("Centerline") has been awarded a MedTech Outlook Award as a 2024 Top Surgical Devices Company. The company is recognized for "Revolutionizing Interventional Procedures with IOPS Technology". Receiving the award, Founder...

at 16:30
K-Bro Linen Inc. ("K-Bro" or the "Corporation") today announces its Q1 2024 financial and operating results. Q1 2024 Financial and Operating Highlights Consolidated revenue increased 13.3% compared to Q1 2023, with healthcare revenue having...

at 16:20
Cartesian Therapeutics, Inc. (the "Company"), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to four new employees. On May 1, 2024,...



News published on and distributed by: